How do you decide on adjuvant therapy in a patient with a Stage IA uterine carcinosarcoma without any myometrial invasion?

1 Answers

Mednet Member

Radiation Oncology · Varian Medical Systems/Allegheny health network

There is no good prospective study. Our approach, based on outcome and retrospective data (including NCDB), is brachy plus chemo.

This is paper I was referring to. With all the caveats of NCDB studies, it givess some objective information where prospective...